Venlafaxine Hydrochloride
Product Images NDC 68071-2703

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-2703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2703 3)

Label for Venlafaxine Hydrochloride 75mg extended-release capsules, package of 30, by NuCare Pharmaceuticals, Inc. The label includes the NDC 68071-2703-3, product number R1621030, and dispensing instructions to take every 8 hours. It also displays manufacturer details for Amneal Pharmaceuticals, Inc. and includes warnings to keep out of reach of children and storage instructions.*

FDA Label Image

Figr1 (Figr1)

A scatter plot chart showing pharmacokinetic (PK) fold changes and 90% confidence interval recommendations for venlafaxine and its metabolite ODV when co-administered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value, indicating pharmacokinetic variability and clinical warnings or dose adjustment recommendations.*

FDA Label Image

Figr2 (Figr2)

A forest plot chart illustrating drug interaction data for various interacting drugs with analytes measuring Cmax and AUC. The plot shows PKFold changes with 90% confidence intervals and provides dosing adjustment recommendations for each drug, ranging from no dose adjustment to cautions or clinical significance unknown. The horizontal axis represents the change relative to the reference value.*

FDA Label Image

Figr3 (Figr3)

A scatter plot chart showing fold changes and 90% confidence intervals for venlafaxine pharmacokinetic parameters (Cmax, AUC) and its active metabolite ODV in various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal (hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender. The x-axis represents change relative to the reference value, with associated dosing recommendations listed for each population group on the right side.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Logo2 (Logo2)

FDA Label Image

Venlafaxinestructure (Venlafaxinestructure)

Chemical structure diagram of venlafaxine hydrochloride showing its molecular configuration, including the chiral center, aromatic ring, and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.